KURA
Kura Oncology·NASDAQ
--
--(--)
--
--(--)
3.47 / 10
Netural
Fundamental assessment: 3.5/10 points to inadequate condition. Positive attributes include Interest coverage ratio (EBIT / Interest expense) (%) and Profit-MV, while weaknesses are evident in PB-ROE and Days sales outstanding. Concluding perspective: guarded.
Analysis Checks(7/10)
Revenue-MV
Value-1.62
Score1/3
Weight7.78%
1M Return4.24%
Value-1.62
Score1/3
Weight7.78%
1M Return4.24%
Days sales outstanding
Value72.55
Score1/3
Weight-2.13%
1M Return-1.57%
Value72.55
Score1/3
Weight-2.13%
1M Return-1.57%
Net income-Revenue
Value-0.17
Score2/3
Weight15.47%
1M Return8.45%
Value-0.17
Score2/3
Weight15.47%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.55%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.55%
1M Return-1.11%
Asset-MV
Value-0.50
Score3/3
Weight28.66%
1M Return13.15%
Value-0.50
Score3/3
Weight28.66%
1M Return13.15%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight1.66%
1M Return1.11%
Value78.47
Score2/3
Weight1.66%
1M Return1.11%
Profit-MV
Value0.46
Score2/3
Weight15.46%
1M Return8.45%
Value0.46
Score2/3
Weight15.46%
1M Return8.45%
PB-ROE
Value0.05
Score1/3
Weight18.82%
1M Return9.57%
Value0.05
Score1/3
Weight18.82%
1M Return9.57%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.64%
1M Return0.43%
Value92.66
Score2/3
Weight0.64%
1M Return0.43%
Cash-MV
Value-0.07
Score2/3
Weight15.20%
1M Return8.41%
Value-0.07
Score2/3
Weight15.20%
1M Return8.41%
Revenue-MV
Value-1.62
Score1/3
Weight7.78%
1M Return4.24%
Value-1.62
Score1/3
Weight7.78%
1M Return4.24%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight1.66%
1M Return1.11%
Value78.47
Score2/3
Weight1.66%
1M Return1.11%
Days sales outstanding
Value72.55
Score1/3
Weight-2.13%
1M Return-1.57%
Value72.55
Score1/3
Weight-2.13%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight15.46%
1M Return8.45%
Value0.46
Score2/3
Weight15.46%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight15.47%
1M Return8.45%
Value-0.17
Score2/3
Weight15.47%
1M Return8.45%
PB-ROE
Value0.05
Score1/3
Weight18.82%
1M Return9.57%
Value0.05
Score1/3
Weight18.82%
1M Return9.57%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.55%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.55%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.64%
1M Return0.43%
Value92.66
Score2/3
Weight0.64%
1M Return0.43%
Asset-MV
Value-0.50
Score3/3
Weight28.66%
1M Return13.15%
Value-0.50
Score3/3
Weight28.66%
1M Return13.15%
Cash-MV
Value-0.07
Score2/3
Weight15.20%
1M Return8.41%
Value-0.07
Score2/3
Weight15.20%
1M Return8.41%
Is KURA undervalued or overvalued?
- KURA scores 3.47/10 on fundamentals and holds a Fair valuation at present. Backed by its -60.25% ROE, -208.48% net margin, -3.46 P/E ratio, 2.81 P/B ratio, and -5.53% earnings growth, these metrics solidify its Netural investment rating.
